Publications by authors named "Jon D Herrington"

Claim this Profile
C
Characterizing the impact of magnesium and potassium-supplemented hydration with cisplatin and the subsequent electrolyte replacement requirements.
So Jung Uhm, Elizabeth Meszaros, Kendall Hammonds, Ina Patel, Jon D Herrington

J Oncol Pharm Pract· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe and prolonged hypocalcemia after a single dose of denosumab for metastatic breast cancer with diffuse bone involvement without prior calcium/vitamin D supplementations.
So Jung Uhm, James A Hall, Jon D Herrington

J Oncol Pharm Pract· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.
Amy Morrow, Campbell Garland, Fei Yang, Mike De Luna, Jon D Herrington

J Oncol Pharm Pract· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered methotrexate clearance in the treatment of CNS lymphoma with concurrent use of nitrofurantoin for a urinary tract infection.
Jasmine L Gowarty, Ina J Patel, Jon D Herrington

J Oncol Pharm Pract· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetirizine versus diphenhydramine in the prevention of chemotherapy-related hypersensitivity reactions.
Charis G Durham, Deepthi Thotakura, Lauren Sager, Jennifer Foster, Jon D Herrington

J Oncol Pharm Pract· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verapamil as a culprit of palbociclib toxicity.
Jasmine L Gowarty, Jon D Herrington

J Oncol Pharm Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegfilgrastim-induced hyperleukocytosis leading to hospitalization of a patient with breast cancer.
Rihin Chavda, Jon D Herrington

Proc (Bayl Univ Med Cent)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
Saeed K Alzghari, Susan E Seago, Jessica E Garza, Yasmeen F Hashimie, Kimberly A Baty, Jon D Herrington

J Oncol Pharm Pract· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancer.
Joseph S Bubalo, Jon D Herrington, Marc Takemoto, Patricia Willman, Michael S Edwards

Support Care Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent gastrointestinal perforation and pulmonary embolism due to bevacizumab in an adult undergoing treatment for stage IV colon cancer.
Sana Qureshi, Ryan B Elliott, Jon D Herrington

J Oncol Pharm Pract· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipping into the Clostridium difficile pool: Are alcohol-based dispensers fomites for C difficile?
James A Hall, Ryan R Keul, Justin D Shanks, Robert Fader, Jon D Herrington

Am J Infect Control· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine.
Saeed K Alzghari, Susan E Seago, Christian T Cable, Jon D Herrington

J Oncol Pharm Pract· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High- versus low-dose leucovorin in the modified FOLFOX6 regimen for first-line treatment of metastatic colorectal cancer.
Jana Reynolds, April Chamberland-Tremblay, Jon D Herrington, Yolanda Munoz Maldonado, Lucas Wong

J Oncol Pharm Pract· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ceftriaxone and cefepime on high-dose methotrexate clearance.
Hieu X Tran, Jon D Herrington

J Oncol Pharm Pract· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytarabine syndrome despite corticosteroid premedication in an adult undergoing induction treatment for acute myelogenous leukemia.
Matthew A Jirasek, Jon D Herrington

J Oncol Pharm Pract· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.
Lily Z Yan, Jon D Herrington

J Oncol Pharm Pract· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine.
Gary Lu, Vinit Karur, Jon D Herrington, Mary G Walker

Proc (Bayl Univ Med Cent)· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed, low-dose rasburicase for the treatment or prevention of hyperuricemia in adult oncology patients.
Jon D Herrington, Brian C Dinh

J Oncol Pharm Pract· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single premedication dose of dexamethasone 20 mg IV before docetaxel administration.
Jyoti D Chouhan, Jon D Herrington

J Oncol Pharm Pract· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
Jyoti D Chouhan, Jon D Herrington

Pharmacotherapy· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Jon D Herrington, Adam D Jaskiewicz, Juhee Song

Cancer· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Sean T Nguyen, Susan A Eaton, Amy M Bain, Anita P Rahman, Kenna D Payne, Jon D Herrington

Pharmacotherapy· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future options for the treatment of chemotherapy-induced anaemia.
Jennifer A Ziegler, Jon D Herrington

Expert Opin Investig Drugs· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia.
Jon D Herrington, Hai T Tran, Mark W Riggs

Cancer Chemother Pharmacol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor lysis syndrome in solid tumors.
Frank E Mott, Alex Esana, Carl Chakmakjian, Jon D Herrington

Support Cancer Ther· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis